|
Volumn 138 Suppl 1, Issue , 2010, Pages 18-22
|
Efficacy and safety of nadroparin and unfractionated heparin for the treatment of venous thromboembolism during pregnancy and puerperium.
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICOAGULANT AGENT;
FIBRINOLYTIC AGENT;
HEPARIN;
NADROPARIN;
ARTICLE;
FEMALE;
HUMAN;
PREGNANCY;
PREGNANCY COMPLICATION;
PUERPERAL DISORDER;
VENOUS THROMBOEMBOLISM;
ANTICOAGULANTS;
FEMALE;
FIBRINOLYTIC AGENTS;
HEPARIN;
HUMANS;
NADROPARIN;
PREGNANCY;
PREGNANCY COMPLICATIONS, CARDIOVASCULAR;
PUERPERAL DISORDERS;
VENOUS THROMBOEMBOLISM;
|
EID: 77951218155
PISSN: 03708179
EISSN: None
Source Type: Journal
DOI: 10.2298/SARH10S1018M Document Type: Article |
Times cited : (7)
|
References (0)
|